In patients with bladder urothelial carcinoma, there was a statistically significant difference in the maximum tumor diameter among the three HER2 expression groups (0/1+, 2+ and 3+, <i>P</i> = 0.041). This evidence concerns the gene ERBB2 and bladder transitional cell carcinoma.